Skip to main content
ISEV2025 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Disease and therapy

Session Name: Poster Session 2

(842) First-in-Man clinical pilot study showing the safety and tolerability of intravenous injection of ER2001 (a self-assembled HTT-specific siRNA) in patients with early manifest HD

Friday, April 25, 2025
16:30 – 17:30 CET

    Presenting Author(s)

  • LL

    Lishan Lin, n/a

    Sun Yat-sen University
    guangzhou, China (People's Republic)